2013 (43 POSTS)
Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL , Kerger BD. 2013. A review of the health hazards posed by cobalt. Crit Rev Toxicol 43(4):316–362; doi:10.3109/10408444.2013.779633 . PMID: 23656559.
View Abstract
Topics: cobalt , risk assessment
Kerger BD, Tvermoes BE, Unice KM, Finley BL , Paustenbach DJ, Galbraith DA. 2013. Cobalt speciation assay for human serum, Part II. Method validation in a study of human volunteers ingesting cobalt (II) chloride dietary supplement for 90 days. Toxicol Environ Chem 95(4):709–718; doi: 10.1080/02772248.2013.792559 .
View Abstract
Topics: cobalt , Exposure Assessment
Kerger BD, Gerads R, Gurleyuk H, Thuett KA, Finley BL , Paustenbach DJ. 2013. Cobalt speciation assay for human serum, Part I. Method for measuring large and small molecular cobalt and protein-binding capacity using size exclusion chromatography with inductively-coupled plasma-mass spectroscopy detection. Toxicol Environ Chem 95(4):687–708; doi: 10.1080/02772248.2013.793444 .
View Abstract
Topics: cobalt
Finley BL , Unice KM, Kerger BD, Otani JM, Paustenbach DJ, Galbraith DA, Tvermoes BE. 2013. 31-day study of cobalt (II) chloride ingestion in humans: Pharmacokinetics and clinical effects. J Toxicol Environ Health A, 76:1210–1224; doi: 10.1080/15287394.2013.848391 . PMID: 24283372.
Topics: cobalt
O’Brien T, Ding H, Suh M , Thompson C , Parsons BL, Harris MA,…, Haws LC , Proctor DM . 2013. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water. Mutat Res 754(1-2):15-21. doi: 10.1016/j.mrgentox.2013.03.008 . PMID: 23583686.
View Abstract
Topics: chromium , water
Sacks NC . 2013. Avoidable costs in U.S. healthcare: The $200 billion opportunity from using medicines more responsibly. IMS Health , June.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Racz L , Baker PA, Duckworth KL, Heline TR, Woodall BD. 2013. Environmental planning while deployed: Mission hindrance or enhancement? Joint Force Quart 70:30–33.
View Abstract
Topics: risk assessment
Flory J, Kanel SR, Racz L , Impellitteri CA, Rendahandi GS, Goltz MN. 2013. Influence of pH on the transport of silver nanoparticles in saturated porous media: Laboratory experiments and modeling. J Nanopart Res 15:1484; doi: 10.1007/s11051-013-1484-x .
View Abstract
Topics: nanomaterials
Chen Q, Jiang X , Hedgeman E, Knutson K, Gillespie B, Hong B, Lepkowski JM, Franzblau A, et al. 2013. Estimation of age-and sex-specific background human serum concentrations of PCDDs, PCDFs, and PCBs in the UMDES and NHANES populations. Chemosphere 91(6):817-23; doi: 10.1016/j.chemosphere.2013.01.078 . PMID: 23466097.
View Abstract
Topics: dioxin , NHANES , PCBs
MacDonell MM, Haroun LA, Teuschler LK, Rice ER, Hertzberg RC, Butler JP, Chang Y, Clark S, Johns AP, Perry CS , Garcia SS, Jacobi JH, Scofield MA. 2013. Cumulative risk assessment toolbox: Methods and approaches for the practitioner. J Toxicol 2013:310904; doi: 10.1155/2013/310904 . PMID: 23762048.
View Abstract
Topics: risk assessment
Sterner TR, Ruark CD, Covington TR , Yu KO, Gearhart JM. 2013. A physiologically based pharmacokinetic model for theoxime TMB-4: Simulation of rodent and human data. Arch Toxicol 87(4):661– 680; doi: 10.1007/s00204-012-0987-z . PMID: 23314320.
View Abstract
Topics: PBPK/PBDE , pharmacokinetics
Gross SA, Avens HJ, Banducci AM, Sahmel J, Panko JM , Tvermoes BE. 2013. Analysis of BTEX groundwater concentrations from surface spills associated with hydraulic fracturing operations. J Air Waste Manage Assoc 63(4):424–432; doi: 10.1080/10962247.2012.759166 . PMID: 23687727.
View Abstract
Topics: benzene , Environmental Science , fracking , water
Olchanski N, McInnis-Myers M, Halseth M, Cyr PL , Bockstedt L, Goss TF, Howland RH. 2013. The economic burden of treatment-resistant depression. Clin Ther 35(4):512-522; doi: 10.1016/j.clinthera.2012.09.001 . PMID: 23490291.
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Thompson CM , Proctor DM , Suh M , Haws LC , Kirman CR, Harris MA. 2013. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol 43(3):244-274; doi: 10.3109/10408444.2013.768596 . PMID: 23445218.
View Abstract
Topics: chromium , Exposure Assessment , mode of action
Shah F, Greene N . 2013. Analysis of Pfizer compounds in EPA’s ToxCast chemicals-assay space. Chem Res Toxicol 27(1):86-98; doi: 10.1021/tx400343t . PMID: 24328225.
View Abstract
Topics: computational toxicology
Naven RT, Swiss R, Klug-McLeod J, Will Y, Greene N . 2013. The development of structure-activity relationships for mitochondrial dysfunction: Uncoupling of oxidative phosphorylation. Toxicol Sci 131(1):271-278; doi: 10.1093/toxsci/kfs279 . PMID: 22977170.
View Abstract
Topics: drug development
Urban JD , Carakostas MC, Brusick DJ. 2013. Steviol glycoside safety: Is the genotoxicity database sufficient? Food Chem Toxicol 51(Jan):386-390; doi: 10.1016/j.fct.2012.10.016 . PMID: 23103588.
View Abstract
Topics: Exposure Assessment , Food science , genotoxicity
2012 (44 POSTS)
Mitchell M , Lowe K, Fryzek J. 2012. A multisource approach to improving epidemiologic estimates: Application to global B-cell malignancies. ISRN Oncol 2012:129713; 10.5402/2012/129713 . PMID: 23346415.
View Abstract
Topics: Cancer , Epidemiology
Naven RT, Greene N , Williams RV. 2012. Latest advances in computational genotoxicity prediction. Exp Opin Drug Metabol 8(12):1579-87; doi: 10.1517/17425255.2012.724059 . PMID: 22998164.
View Abstract
Topics: computational toxicology , genotoxicity
Schugg TT, Erlebacher A, Leibowitz S, Ma L, Muglio LJ, Rando OJ, Rogers JM , Romero R, von Saal FS, Wise LD. 2012. Fetal programming and environmental exposures: Implications for prenatal care and preterm birth. Ann NY Acad Sci 1276(1):37–46; doi: 10.1111/nyas.12003 . PMID: 23278645.
View Abstract